advanced search

Welcome: Guest

log in

Cough, Cold and Allergy (hay Fever) Remedies in China

Publication Date September 2009
Publisher Euromonitor
Product Type Report
Pages 52
ISBN Number not applicable
Product Code EUR00705
Buy this product or for assistance call +44 20 7060 7474

Summary

Euromonitor International's Cough, Cold and Allergy Products in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage:

market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

  • Get a detailed picture of the cough, cold and allergy (hayfever) industry
  • Identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content

  • Cough, Cold and Allergy (hay Fever) Remedies in China
  • Euromonitor International
  • September 2009
  • Headlines
  • Trends
  • Switches
  • Competitive Landscape
  • Prospects
  • Sector Data
    • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
    • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
    • Table 3 Sales of Decongestants by Type: Value 2003-2008
    • Table 4 Sales of Decongestants by Type: % Value Growth 2003-2008
    • Table 5 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
    • Table 6 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
    • Table 7 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
    • Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
    • Table 9 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
    • Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
    • Table 11 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
  • Amway (china) Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary1 Amway (China) Co Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary2 Amway (China) Co Ltd: Competitive Position 2008
  • Bristol-Myers Squibb (shanghai) Trading Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary3 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts
  • Company Background
  • Production
    • Summary4 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Production Statistics 2008
  • Competitive Positioning
    • Summary5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2008
  • GlaxoSmithKline (tianjin) Pharm Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary6 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Key Facts
  • Company Background
  • Production
    • Summary7 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Production Statistics 2008
  • Competitive Positioning
    • Summary8 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Competitive Position 2008
  • Jiangzhong Pharmaceutical Co
  • Strategic Direction
  • Key Facts
    • Summary9 Jiangzhong Pharmaceutical Co Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary10 Jiangzhong Pharmaceutical Co Ltd: Competitive Position 2008
  • Sanjiu Enterprise Group
  • Strategic Direction
  • Key Facts
    • Summary11 Sanjiu Enterprise Group: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary12 Sanjiu Enterprise Group: Competitive Position 2008
  • Tianjin Tianshi Biological Development Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary13 Tianjin Tianshi Biological Development Co Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary14 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2008
  • Tibet Linzhi Qizheng Tibetan Medicine Fty
  • Strategic Direction
  • Key Facts
    • Summary15 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts
  • Company Background
  • Production
    • Summary16 Tibet Linzhi Qizheng Tibetan Medicine Fty: Production Statistics 2007
  • Competitive Positioning
    • Summary17 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2008
  • Wyeth Pharmaceutical Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary18 Wyeth Pharmaceutical Co Ltd: Key Facts
  • Company Background
  • Production
    • Summary19 Wyeth Pharmaceutical Co Ltd: Production Statistics 2008
  • Competitive Positioning
    • Summary20 Wyeth Pharmaceutical Co Ltd: Competitive Position 2008
  • Xian Janssen Pharmaceutical Ltd
  • Strategic Direction
  • Key Facts
    • Summary21 Xian Janssen Pharmaceutical Ltd: Key Facts
  • Company Background
  • Production
  • Competitive Positioning
    • Summary22 Xian Janssen Pharmaceutical Ltd: Competitive Position 2008
  • Yunnan Baiyao Group Co Ltd
  • Strategic Direction
  • Key Facts
    • Summary23 Yunnan Baiyao Group Co Ltd: Key Facts
  • Company Background
  • Production
    • Summary24 Yunnan Baiyao Group Co Ltd: Production Statistics 2008
  • Competitive Positioning
    • Summary25 Yunnan Baiyao Group Co Ltd: Competitive Position 2008
  • Executive Summary
  • Growing Health Awareness and Disposable Incomes Fuel Growth
  • Vitamins and Dietary Supplements Lead Growth
  • Amway Leads Fragmented OTC Healthcare
  • Chemists/pharmacies Lead But Direct Selling Grows Fastest
  • Steady Growth for Forecast Period
  • Key Trends and Developments
  • Rising Health-consciousness and Self-medication
  • Convenience Becomes Increasingly Important
  • Lifestyle Changes Shape Growth
  • Players Increasingly Focus on Specific Consumer Targets
  • Deep-rooted Tradition Impacts OTC Healthcare
  • Territory Key Trends and Developments
  • East China
  • Mid China
  • North and Northeast China
  • Northwest China
  • South China
  • Southwest China
  • Market Indicators
    • Table 12 Consumer Expenditure on Health Goods and Medical Services 2003-2008
    • Table 13 Life Expectancy at Birth 2003-2008
  • Market Data
    • Table 14 Sales of OTC Healthcare by Sector: Value 2003-2008
    • Table 15 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
    • Table 16 Sales of OTC Healthcare by Region: Value 2003-2008
    • Table 17 Sales of OTC Healthcare by Region: % Value Growth 2003-2008
    • Table 18 OTC Healthcare Company Shares by Value 2004-2008
    • Table 19 OTC Healthcare Brand Shares by Value 2005-2008
    • Table 20 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
    • Table 21 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
    • Table 22 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
    • Table 23 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
    • Table 24 Forecast Sales of OTC Healthcare by Region: Value 2008-2013
    • Table 25 Forecast Sales of OTC Healthcare by Region: % Value Growth 2008-2013
    • Appendix
  • OTC Registration and Classification
  • Vitamins & Dietary Supplements Registration and Classification
  • Self-medication and Preventative Medicine
  • Generics
  • Switches
    • Summary26 OTC Healthcare Switches 2005-2007
  • Definitions
    • Summary27 Research Sources

Industry Events

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>